# Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMS

> **NCT01709812** · PHASE4 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Relapsing-remitting Multiple Sclerosis

## Interventions

- **OTHER:** individualized patient support program
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT01709812
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709812, "Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMS". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01709812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*